P-441 Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study
Clinical Lymphoma Myeloma and Leukemia(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Clinical Lymphoma Myeloma and Leukemia(2023)